- Home
- INVE vs TVGN Comparison
INVE vs TVGN Comparison
Compare INVE & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.62
Company Overview
Basic Information| Metric | INVE | TVGN |
|---|---|---|
| Founded | 1990 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Blank Checks |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.8M | 63.9M |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | INVE | TVGN |
|---|---|---|
| Price | $4.62 | $6.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 272.1K | 21.3K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $60,219,000.00 | N/A |
| Revenue This Year | $22.10 | N/A |
| Revenue Next Year | $20.74 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.21 | N/A |
| 52 Week Low | $3.08 | $0.14 |
| 52 Week High | $4.84 | $10.76 |
Technical Indicators
Market Signals| Indicator | INVE | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 76.30 | 54.94 |
| Support Level | $3.25 | $0.47 |
| Resistance Level | N/A | $9.40 |
| Average True Range (ATR) | 0.22 | 0.86 |
| MACD | 0.09 | -0.07 |
| Stochastic Oscillator | 83.80 | 32.28 |
Price Performance
Historical Comparison INVE
TVGN
About INVE Identiv Inc.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.
About TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.